mRNA Flu Vaccine Gets FDA Approval | Science News

The U.S. just approved a groundbreaking mRNA flu vaccine, mFlusiva from Moderna, that’s up to 27% more effective than the standard shot—especially for adults 50 and older. After initial hesitation, the FDA reversed course, paving the way for this faster, more adaptable vaccine that could revolutionize flu season preparedness and offer stronger protection for vulnerable populations. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/28dc53cc9aa33998